BioSpace News Archive

This is a basic recommendation of the Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA) in Vienna (Austria), which has published the results of a large-scale international study of this topic.

Digital marketing agency Doctor Multimedia announced that the Wolf of Wall Street Jordan Belfort will be training their sales team in an exclusive one-day seminar at the Fairmont Grand Del Mar on April 23, 2019.

BioNJ’s Ninth Annual BioPartnering Conference, scheduled for Wednesday, May 8, 2019 at The Palace at Somerset Park, Somerset, NJ, will bring together more than 400 life sciences professionals from the Northeast to Mid-Atlantic states for a day of networking, 1:1 partnering meetings, company presentations, posters, exhibits and plenary sessions.

Sanofi Genzyme announced that Health Canada has issued a Notice of Compliance with conditions for LibtayoTM for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or curative radiation.

NBE-Therapeutics develops next-generation iADC products with the aim to improve the outcome for cancer patients, as it continues to develop iADCs based on its proprietary technology platforms.

Proactive innovation specialists located in Asia, Europe and the United States to combine Research and Development efforts

Abiomed, Inc. (NASDAQ: ABMD) announced that on Thursday, May 2, 2019, the Company will release financial results for the fourth quarter of fiscal 2019.

Polsinelli, an Am Law 100 firm, announces the establishment of Polsinelli Healthcare Solutions, a healthcare consulting entity that assists clients with a range of healthcare strategic and operational issues.

Abbott (NYSE: ABT) and its foundation, the Abbott Fund, are providing more than $500,000 in grants and healthcare products to support relief efforts for Cyclone Idai in Southeast Africa, including Mozambique, Malawi and Zimbabwe.

As concerns mount about the overuse of powerful and costly diagnostic imaging tests, such as CT scans and MRIs, a new study from MIT suggests that software designed to help doctors make better decisions could decrease certain scans by about 6%.